C Ingvar
Overview
Explore the profile of C Ingvar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Narbe U, Bendahl P, Ferno M, Ingvar C, Dihge L, Ryden L
Br J Surg
. 2021 Oct;
108(12):1465-1473.
PMID: 34636842
Background: The St Gallen 2019 guidelines for primary therapy of early breast cancer recommend omission of completion axillary lymph node dissection (cALND), regardless of histological type, in patients with one...
2.
Ingvar C, Ahlgren J, Emdin S, Lofgren L, Nordander M, Nimeus E, et al.
Br J Surg
. 2020 Apr;
107(10):1299-1306.
PMID: 32335901
Background: The implementation of screening programmes in Sweden during the mid-1990s increased the number of small node-negative breast cancers. In this era before staging by sentinel node biopsy, routine axillary...
3.
Isaksson K, Mikiver R, Eriksson H, Lapins J, Nielsen K, Ingvar C, et al.
Br J Dermatol
. 2020 Mar;
184(1):60-67.
PMID: 32133615
Background: The incidence of cutaneous malignant melanoma (CMM) continues to increase in most countries worldwide and the majority are diagnosed with thin tumours (≤ 1 mm). Objectives: The aim of...
4.
Lyth J, Falk M, Maroti M, Eriksson H, Ingvar C
J Eur Acad Dermatol Venereol
. 2017 Apr;
31(9):1468-1474.
PMID: 28419674
Background: Prognostic factors in patients with localized primary cutaneous malignant melanoma (CMM) are well described. However, prognostic factors for recurrence are less documented. Objectives: The aim of this study was...
5.
Lyth J, Mikiver R, Nielsen K, Isaksson K, Ingvar C
Eur J Cancer
. 2016 Apr;
59:171-178.
PMID: 27046697
Background: Several major analyses have identified a consistent set of independent risk factors for cutaneous malignant melanoma (CMM). A few prognostic models have been presented but some are based on...
6.
Lindqvist P, Epstein E, Nielsen K, Landin-Olsson M, Ingvar C, Olsson H
J Intern Med
. 2016 Mar;
280(4):375-87.
PMID: 26992108
Objective: Women with active sunlight exposure habits experience a lower mortality rate than women who avoid sun exposure; however, they are at an increased risk of skin cancer. We aimed...
7.
Lyth J, Eriksson H, Hansson J, Ingvar C, Jansson M, Lapins J, et al.
Br J Dermatol
. 2014 Oct;
172(3):700-6.
PMID: 25323770
Background: Both patient survival and the proportion of patients diagnosed with thin cutaneous malignant melanoma (CMM) have been steadily rising in Sweden as in most Western countries, although the rate...
8.
Lindqvist P, Epstein E, Landin-Olsson M, Ingvar C, Nielsen K, Stenbeck M, et al.
J Intern Med
. 2014 Apr;
276(1):77-86.
PMID: 24697969
Background: Sunlight exposure and fair skin are major determinants of human vitamin D production, but they are also risk factors for cutaneous malignant melanoma (MM). There is epidemiological evidence that...
9.
Ekedahl H, Cirenajwis H, Harbst K, Carneiro A, Nielsen K, Olsson H, et al.
Br J Dermatol
. 2013 Jul;
169(5):1049-55.
PMID: 23855428
Background: BRAF and NRAS mutations are frequently found in melanoma tumours, and recently developed BRAF-targeted therapies demonstrate significant clinical benefit. Objectives: We sought to investigate the clinical significance of BRAF...
10.
Eriksson H, Lyth J, Mansson-Brahme E, Frohm-Nilsson M, Ingvar C, Lindholm C, et al.
Eur J Cancer
. 2013 Apr;
49(12):2705-16.
PMID: 23583439
Background: A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between level of education, clinical stage at diagnosis...